Danaher Co. (NYSE:DHR) Shares Purchased by Reynders McVeigh Capital Management LLC

Reynders McVeigh Capital Management LLC grew its holdings in Danaher Co. (NYSE:DHR) by 2.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 228,453 shares of the conglomerate’s stock after purchasing an additional 5,458 shares during the quarter. Danaher comprises about 2.8% of Reynders McVeigh Capital Management LLC’s portfolio, making the stock its 8th biggest position. Reynders McVeigh Capital Management LLC’s holdings in Danaher were worth $52,441,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in DHR. Heck Capital Advisors LLC bought a new position in shares of Danaher during the 4th quarter worth approximately $27,000. Decker Retirement Planning Inc. bought a new stake in shares of Danaher in the 4th quarter valued at $31,000. Golden State Wealth Management LLC acquired a new position in shares of Danaher during the 4th quarter valued at $31,000. Strategic Financial Concepts LLC bought a new position in Danaher during the fourth quarter worth $31,000. Finally, Pineridge Advisors LLC grew its holdings in Danaher by 63.3% in the fourth quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate’s stock worth $34,000 after purchasing an additional 57 shares during the period. Institutional investors own 79.05% of the company’s stock.

Insider Transactions at Danaher

In related news, SVP Brian W. Ellis sold 5,700 shares of Danaher stock in a transaction on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the completion of the sale, the senior vice president now owns 20,230 shares of the company’s stock, valued at approximately $4,534,149.90. This trade represents a 21.98 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 11.10% of the company’s stock.

Danaher Price Performance

Shares of NYSE:DHR opened at $188.75 on Friday. The company has a market capitalization of $134.90 billion, a P/E ratio of 35.75, a price-to-earnings-growth ratio of 2.66 and a beta of 0.86. The company’s 50-day moving average is $203.71 and its 200 day moving average is $229.91. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40. Danaher Co. has a fifty-two week low of $171.00 and a fifty-two week high of $281.70.

Danaher (NYSE:DHR) last issued its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, meeting the consensus estimate of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period last year, the firm earned $2.09 EPS. On average, equities research analysts forecast that Danaher Co. will post 7.63 earnings per share for the current year.

Danaher Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be issued a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a yield of 0.68%. The ex-dividend date of this dividend is Friday, March 28th. This is a positive change from Danaher’s previous quarterly dividend of $0.27. Danaher’s payout ratio is presently 24.24%.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on the stock. Barclays raised shares of Danaher from an “equal weight” rating to an “overweight” rating and cut their price objective for the stock from $240.00 to $205.00 in a research report on Thursday. Scotiabank assumed coverage on Danaher in a research report on Monday, December 23rd. They set a “sector perform” rating and a $265.00 target price on the stock. Robert W. Baird cut their target price on Danaher from $277.00 to $268.00 and set an “overweight” rating on the stock in a report on Tuesday, January 28th. Royal Bank of Canada restated an “outperform” rating and set a $277.00 price target (down previously from $299.00) on shares of Danaher in a research note on Thursday, January 30th. Finally, The Goldman Sachs Group raised shares of Danaher from a “neutral” rating to a “buy” rating and set a $260.00 price objective on the stock in a research note on Friday, March 21st. Four research analysts have rated the stock with a hold rating and eighteen have issued a buy rating to the company. According to data from MarketBeat.com, Danaher currently has an average rating of “Moderate Buy” and an average target price of $276.57.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.